MYND Life Sciences Working On Truly Novel Research For Depressive And Neurological Diseases Jun 24, 2021
Mountain Valley MD Provides Update on Key Strategic Initiatives: Patent Award, FDA Collaborative Research Agreement,… Jun 24, 2021
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other… Jun 24, 2021
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004 Jun 24, 2021
Strong Psychedelic Data In 1H 2021 Sets The Stage For Key Endpoint Results Later This Year Jun 23, 2021
MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and related forms of Dementia with… Jun 23, 2021
